Harmony Gold Mining reports 61% operating profit surge but output decline and copper capex weigh on HMY stock
Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
Read More 6 minute read Healthcare Industry News GlucoTrack stock alert: Why are shareholders planning to sell 20 million shares of GCTK? GlucoTrack (NASDAQ: GCTK) shareholders plan to sell 20M shares. Discover what this means for investors, dilution risks, and biotech stock sentiment. byPallavi MadhirajuSeptember 30, 2025